Dr. Kevin Lee serves as the Chief Executive Officer of Bicycle Therapeutics, leading the clinical-stage biopharmaceutical enterprise through its strategic restructuring phases and pipeline clinical trials. Under his executive direction, the management team focuses on advancing proprietary bicyclic peptide technology platforms designed to create targeted precision therapeutics for oncology and severe immunological diseases.